To ensure Humira maintains its potency and effectiveness when you’re ready to inject it, you will need to keep it ...
A retrospective cohort study in the Netherlands evaluated the real-world effectiveness of the biosimilar adalimumab Hyrimoz ...
Half advice show. Half survival guide. Half absurdity-fest. (Wait, how does this work again? We're not numbers people.) Each episode, we answer all your burning questions, from how to survive a public ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...
PsiThera, formerly Psivant Therapeutics, raised just over $47 million for oral drugs targeting “diseases long-constrained by ...
Months after the Ford government pulled funding and forced several supervised consumption sites to close, the City of Toronto is reporting an increase in visible drug use and calls to clean up needles ...
To better understand which social media platforms Americans use, Pew Research Center surveyed 5,022 U.S. adults from Feb. 5 to June 18, 2025. SSRS conducted this National Public Opinion Reference ...
Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...
Zacks Investment Research on MSNOpinion
3 generic drug stocks to watch amid changing US landscape
Generic drugmakers continue to navigate a challenging U.S. market defined by persistent price erosion, intense competition ...
Kristie Reed, PharmD, oversees emergency, general medical, surgical, psychiatric care, and oncology medication as the pharmacy director of a community hospital. Dr. Reed specializes in IV medications.
So, Regeneron's revenue rose 1.9% from $3.68 billion in Q2 2025 to $3.75 billion, beating consensus estimate by $160 million ...
Sandoz, Teva and Dr. Reddy's emerge as standouts as generic drugmakers lean on biosimilars, complex generics and tighter cost controls.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果